The Effect of an Educational Intervention on Adherence to Intraocular Pressure-Lowering Medications in a Large Cohort of Older Adults with Glaucoma

Fiscella, Richard G.; Caplan, Eleanor O.; Kamble, Pravin; Bunniran, Suvapun; Uribe, Claudia; Chandwani, Hitesh

doi:10.18553/jmcp.2018.17465

Cited by 11 publications

(11 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Having access to electronic information should improve adherence; hence, Newman-Casey [21] and Fiscella [22] showed in studies that neither the availability of information sent via mail nor access to electronic information improved adherence.…”

Section: Patient's Adherencementioning

confidence: 99%

Influence of Cost of Care and Adherence in Glaucoma Management: An Update

Meier-Gibbons

Töteberg‐Harms

2020

Journal of Ophthalmology

View full text Add to dashboard Cite

e costs for glaucoma care are rising worldwide. e main reason is the increase of life expectancy and the increasing variety of diagnostic tests and therapeutically options by implants and devices. How can we influence the increase in costs? Does a relationship exist between the rising costs and the behavior of patients especially in regard to adherence of patients to the prescribed therapy? Are there ways to improve adherence? e costs of a disease can be estimated by adding the direct costs and the indirect costs deriving from the disease. Many studies have been looking at the direct costs, for example, the costs of diagnostic tests and treatment modalities. Unfortunately, not many studies investigated the indirect costs, i.e., costs related to the need of a person to accompany the patient during his or her outpatient visits or the costs deriving from loss of work capacity because of the disease itself or the outpatient visits. Adherence or the synonym compliance has been discussed since many years, and it seems that it remains a major problem in the management of many chronic diseases. Despite all efforts to improve adherence, the adherence rate in chronic diseases such as glaucoma or arterial hypertension remains considerably low. One of the main factors in improving adherence is raising patient's awareness of the disease by providing general understanding of their disease. Other important factors are simplified therapeutic regimens, e.g., fixed combination drops, sustained drug release techniques, or new glaucoma surgical procedures with a more favorable risk profile.

show abstract

Section: Patient's Adherencementioning

confidence: 99%

Influence of Cost of Care and Adherence in Glaucoma Management: An Update

Meier-Gibbons

Töteberg‐Harms

2020

Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

“…Concurrently, escalating utilization requirements make drug prices a key economic barrier to treatment adherence. In a survey of patients at two USbased glaucoma clinics, 40% of non-adherent patients cited drug costs as a barrier to compliance [32]. These same patients also cited forgetfulness, difficulty with self-administration, and skepticism about glaucoma's blinding effects as barriers to pharmacotherapy adherence.…”

Section: Treatment Optionsmentioning

confidence: 99%

Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation

et al. 2019

View full text Add to dashboard Cite

Glaucoma is a chronic, debilitating disease and a leading cause of global blindness. Despite treatment efforts, 10% of patients demonstrate loss of vision. In the US, [ 80% of glaucoma cases are classified as open-angle glaucoma (OAG), with primary open-angle (POAG) being the most common. Although there has been tremendous innovation in the surgical treatment of glaucoma as of late, two clinical variants of OAG, normaltension glaucoma (NTG) and severe POAG, are especially challenging for providers because patients with access to care and excellent treatment options may progress despite achieving a ''target'' intraocular pressure value. Additionally, recent research has highlighted the importance of nocturnal IOP control in avoiding glaucomatous disease progression. There remains an unmet need for new treatment options that can effectively treat NTG and severe POAG patients, irrespective of baseline IOP, while overcoming adherence limitations of current pharmacotherapies, demonstrating a robust safety profile, and more effectively controlling nocturnal IOP.

show abstract

“…7 Interventions for the improvement of medication nonadherence, including educational materials, counseling, simplification of the medication regimen, and reminders delivered telephonically or via smartphone app, have had only modest effect. [8][9][10][11][12][13][14] Incentives, including rewards or inducements for behavior change, may be an effective intervention and have had positive effects on various health behaviors, including medication adherence. 13 In order to better understand how these incentives modify medication adherence, researchers have begun to use behavioral economics, based on the theory that human choices are not perfectly rational and that how individuals value their future health affects their decision making in the present.…”

Section: What This Study Addsmentioning

confidence: 99%

Perceived appropriateness of medication adherence incentives

Hastings

Hohmann

Jeminiwa

et al. 2021

JMCP

View full text Add to dashboard Cite

BACKGROUND: 50% of prescriptions dispensed in the United States are not taken as prescribed, leading to approximately 125,000 deaths and 10% of hospitalizations per year. Incentives are effective in improving medication adherence; however, information about patient perceptions regarding incentives is lacking. OBJECTIVES:To (1) explore perceived appropriateness of incentives among patients prescribed at least 1 medication for chronic hypertension, hyperlipidemia, heart disease, diabetes, and/or asthma/chronic obstructive pulmonary disease and (2) examine associations between perceived appropriateness and patient characteristics. METHODS:A cross-sectional online survey was administered via Qualtrics Panels to US adults taking at least 1 prescription medication for a chronic condition. The results describe patient preference for financial or social recognition-based incentive, perceived appropriateness of adherence incentives (5-point Likert scale), self-reported adherence (Medometer), and demographics. Analyses included descriptive statistics with chi-square and independent t-tests comparing characteristics between participants who perceived incentives as being appropriate or inappropriate and logistic regression to determine predictors of perceived appropriateness.RESULTS: 1,009 individuals completed the survey. Of the 1,009 total survey participants, 933 (92.5%) preferred to receive a financial (eg, cash, gift card, or voucher) rather than a social recognition-based incentive (eg, encouraging messages, feedback, individual recognition, or team competition) for medication adherence. 740 participants (73%)

show abstract

The Effect of an Educational Intervention on Adherence to Intraocular Pressure-Lowering Medications in a Large Cohort of Older Adults with Glaucoma

Abstract: This study was sponsored by Allergan plc (Dublin, Ireland). Fiscella and Chandwani are employees of Allergan plc. Caplan, Kamble, Bunniran, and Uribe are employees of Comprehensive Health Insights, a Humana company. The authors did not receive honoraria or other payments for authorship.

Cited by 11 publications

References 60 publications

Influence of Cost of Care and Adherence in Glaucoma Management: An Update

Influence of Cost of Care and Adherence in Glaucoma Management: An Update

Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation

Perceived appropriateness of medication adherence incentives

Contact Info

Product

Resources

About